Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youhong Cui

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Cancer Research|January 7, 2014
Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genesLeina Ma, Jia Liu, Limei Liu, et al.
Hepatology (Baltimore, Md.)|April 5, 2012
Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinomaJuanjuan Shan, Junjie Shen, Limei Liu, et al.
Frontiers in Immunology|August 24, 2023
Comparative effects of hepatocyte growth factor and tacrolimus on acute liver allograft early toleranceQuanyu Chen, Zhiqing Yang, Heng Lin, et al.
Signal Transduction and Targeted Therapy|March 11, 2022
Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomasYan-Xia Wang, Haibo Wu, Yong Ren, et al.
Cancer Cell|March 24, 2023
Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for gliomaHaofei Liu, Qiwen Zhao, Leyong Tan, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Cancer Research|January 7, 2014
Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genesLeina Ma, Jia Liu, Limei Liu, et al.
Hepatology (Baltimore, Md.)|April 5, 2012
Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinomaJuanjuan Shan, Junjie Shen, Limei Liu, et al.
Frontiers in Immunology|August 24, 2023
Comparative effects of hepatocyte growth factor and tacrolimus on acute liver allograft early toleranceQuanyu Chen, Zhiqing Yang, Heng Lin, et al.
Signal Transduction and Targeted Therapy|March 11, 2022
Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomasYan-Xia Wang, Haibo Wu, Yong Ren, et al.
Cancer Cell|March 24, 2023
Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for gliomaHaofei Liu, Qiwen Zhao, Leyong Tan, et al.
Pageof 4